Neurotherapeutics & Clinical Trials
This session provides a comprehensive review of the drug development lifecycle, ethical frameworks, and recent trial outcomes for emerging neurological therapies. Topics include novel drug delivery methods crossing the blood-brain barrier, adaptive clinical trial designs, and real-world evidence integration. Industry pioneers and regulatory experts at Stroke 2027 will analyze successful phase III trials, safety monitoring protocols, and global market access challenges. Participants will learn how to critically evaluate emerging clinical literature, enabling them to safely adopt next-generation therapeutics.